|
Volumn 72, Issue 16, 2009, Pages 1447-1448
|
Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study [2]
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
BRAIN HEMORRHAGE;
HUMAN;
LETTER;
PLEIOTROPY;
PRIORITY JOURNAL;
RISK FACTOR;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
VALIDATION PROCESS;
CEREBROVASCULAR ACCIDENT;
CEREBROVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
FALSE POSITIVE RESULT;
FOLLOW UP;
HUMAN TISSUE;
LACUNAR STROKE;
RISK ASSESSMENT;
BLOOD CLOTTING;
BLOOD CLOTTING DISORDER;
BRAIN ARTERY;
BRAIN ATHEROSCLEROSIS;
BRAIN INFARCTION;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG TOXICITY;
EPIDEMIOLOGY;
HYPERCHOLESTEROLEMIA;
IATROGENIC DISEASE;
METABOLISM;
NOTE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
STATISTICS;
BLOOD COAGULATION;
BLOOD COAGULATION DISORDERS;
BRAIN INFARCTION;
CAUSALITY;
CEREBRAL ARTERIES;
CEREBRAL HEMORRHAGE;
CLINICAL TRIALS AS TOPIC;
DRUG TOXICITY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
IATROGENIC DISEASE;
INTRACRANIAL ARTERIOSCLEROSIS;
STROKE;
|
EID: 67449132299
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/01.wnl.0000346744.56398.e5 Document Type: Letter |
Times cited : (6)
|
References (5)
|